Clinical trial
A 16-Week, Single-Blind Randomized, Placebo- Controlled Food Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073368 is registered in ClinicalTrials.gov with Axcella Health, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 16-Week, Single-Blind Randomized, Placebo- Controlled Food Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
- Lead sponsor
- Axcella Health, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 3, 2018
- Completion date
- September 3, 2020
- Enrollment
- 112 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
nafld